We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
1.Ala, FA, Shearman, DJ.A case of autoimmune haemolytic anemia, thrombocytopenia and Landry-Guillain-Barré syndrome. Acta Haematol. 1965;34(6):361–9.Google Scholar
2
2.Guar, S, Sudhathi, R, Baumann, MA.Acute inflammatory demyelinating polyneuropathy concurrent with Evans syndrome. Southern Med J. 2003;96(1):106–7.CrossRefGoogle Scholar
3
3.Knecht, H, Baumberger, M, Tobon, A, Steck, A.Sustained remission of CIDP associated with Evans syndrome. Neurology. 2004;63(4):730–2.Google Scholar
4
4.Marsh, EA, Hirst, CL, Llewelyn, JG, et al. Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy. J Neurol. 2010;257(6):913–9.Google Scholar
5
5.European Federation of Neurological Societies/Peripheral Nerve Society Guideline on Management of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. First Revision. J Peripher Nerv Syst. 2010;15:185–95.Google Scholar
6
6.Arndt, PA, Leger, RM, Garratty, G.Serology of antibodies to secondand third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion. 1999;39(11–12):1239–46.Google Scholar
7
7.Stahl, D, Lacroix-Desmazes, S, Heudes, D, Mouthon, L, Kaveri, SV, Kazatchkine, MD.Altered control of self-reactive IgG by autologous IgM in patients with warm autoimmune hemolytic anemia. Blood. 2000;95(1):328–35.Google Scholar